What blood tests mean in HELLP syndrome
Part of Women’s health & pregnancy clinical trials.
This study looks at blood tests for inflammation and platelet cells in women with HELLP syndrome after a C-section. It aims to help doctors better understand this condition and predict outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and between 18 and 45 years old.
- Your pregnancy is between 28 and 41 weeks.
- You have been diagnosed with HELLP syndrome (a severe form of preeclampsia).
- You have had a C-section and are now in the intensive care unit (ICU).
- You are carrying only one baby (not twins or more) and the baby does not have any known birth defects or chromosome problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood-flow and artery health signs during pregnancy to better understand why preeclampsia happens. It compares women with preeclampsia to women with an uncomplicated pregnancy, and may help improve early detection and care.
This study tests a new approach to prevent long-term heart and kidney problems in people who had preeclampsia, HELLP syndrome, or kidney disease during pregnancy. It aims to see if early follow-up care can improve future health.
This study compares a blood test (sCD163) in women with HELLP syndrome (a serious pregnancy complication) versus healthy pregnant women. It aims to see if this marker can help diagnose or understand HELLP better.
This study looks at people with preeclampsia during pregnancy and how their lung blood pressure and related symptoms change after delivery. It may help doctors better monitor and manage postpartum risks, especially involving the heart and lungs.
This study looks at blood vessel function in pregnant people with preeclampsia to see if it can help predict outcomes. It involves non-invasive measures and routine blood tests.
This study tests a new blood test to track how the body responds to treatment during pregnancy, especially for those at risk of high blood pressure conditions. It may help doctors monitor and improve care.
Hear when a new HELLP Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.